Journal
/
Imunologia e Infecção
/
Lentiviral CRISPR/Cas9介导基因组编辑，用于疾病模型中造血细胞的研究
JoVE Journal
Imunologia e Infecção
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Imunologia e Infecção
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Please note that all translations are automatically generated. Click here for the English version.

Lentiviral CRISPR/Cas9介导基因组编辑，用于疾病模型中造血细胞的研究

11,769 Views

•

08:14 min

•

October 03, 2019

DOI:

10.3791/59977-v

DOI:
10.3791/59977-v

•

08:14 min
October 03, 2019

•

6 Views
, , , , , , , ,
1Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center,University of Virginia School of Medicine

Tags

LentiviralCRISPR/Cas9Genome EditingHematopoietic CellsDisease ModelsTransgene Delivery293T CellsViral TiterBone IsolationHematopoietic Stem Cells

Read Article

Cite this Article

Sano, S., Wang, Y., Evans, M. A., Yura, Y., Sano, M., Ogawa, H., Horitani, K., Doviak, H., Walsh, K. Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models. J. Vis. Exp. (152), e59977, doi:10.3791/59977 (2019).

Download .ris file

Copy

Share Video

.

Copy